T1	p 140 172	patients undergoing laparatomy .
T2	p 450 482	patients undergoing laparotomy .
T3	p 491 563	Eighty patients ( 18 to 65 years of age ) undergoing elective laparotomy
T4	p 1921 1953	patients undergoing laparotomy .
T5	p 2049 2081	patients undergoing laparatomy .
T6	i 21 98	preoperative oral pregabalin and perioperative intravenous lidocaine infusion
T7	i 223 300	preoperative oral pregabalin and perioperative intravenous lidocaine infusion
T8	i 470 482	laparotomy .
T9	i 638 886	placebo capsules and normal saline infusion perioperatively ( control ) ; group L , placebo capsules and lidocaine 1 mg?kg intravenous bolus dose followed by 2 mg?kg?h infusion until skin closure ; group P , 150 mg oral pregabalin and normal saline
T10	i 945 974	oral pregabalin and lidocaine
T11	i 1602 1670	Preoperative oral pregabalin and perioperative intravenous lidocaine
T12	i 1807 1816	lidocaine
T13	i 1941 2015	laparotomy . Therefore , preoperative pregabalin with or without lidocaine
T14	o 102 136	postoperative morphine requirement
T15	o 304 446	postoperative morphine requirement , adverse effects , patients ' satisfaction , mobilization , time to first defecation and time to discharge
T16	o 1000 1213	skin closure . Hemodynamic parameters , visual analogue scale ( VAS ) scores , analgesic consumption , side effects , time to mobilization , time to first defecation , time to discharge and patients ' satisfaction
T17	o 1238 1248	VAS scores
T18	o 1690 1776	postoperative VAS scores . Preoperative oral pregabalin decreased morphine requirement
T19	o 1898 1917	incidence of nausea